Medication for compulsive disorder
Pro Research Analysisby 
Searched over 200M research papers
Pharmacological Treatments for Compulsive Disorders
Compulsive Buying Disorder: Limited Pharmacological Options
Compulsive Buying Disorder (CBD) lacks a definitive pharmacological treatment. A review of 21 studies identified several drug classes, including antidepressants, mood stabilizers, opioid antagonists, second-generation antipsychotics, and NMDA receptor antagonists, but none showed consistent efficacy . Placebo-controlled trials for fluvoxamine were ineffective, while open-label trials for citalopram and escitalopram showed initial promise but failed in double-blind phases . Memantine showed effectiveness in a pilot study, and other drugs like fluoxetine, bupropion, and naltrexone were only effective in isolated clinical cases . Thus, no specific pharmacologic agent can currently be recommended for CBD, highlighting the need for further research.
Obsessive-Compulsive Disorder: Established and Emerging Treatments
First-Line Treatments: SSRIs and Clomipramine
Selective serotonin reuptake inhibitors (SSRIs) and clomipramine are the first-line pharmacological treatments for Obsessive-Compulsive Disorder (OCD) Kaplan2003Del Casale2019. SSRIs such as fluvoxamine, fluoxetine, sertraline, and paroxetine are FDA-approved and have shown significant efficacy in reducing OCD symptoms . Clomipramine, a tricyclic antidepressant, is also effective but has a higher side effect profile, including a risk of seizures .
Treatment-Resistant OCD: Augmentation Strategies
For patients resistant to first-line treatments, several strategies have been explored. Augmentation with antipsychotics like risperidone and aripiprazole has shown positive results in multiple randomized controlled trials (RCTs) . Cognitive-behavioral therapy (CBT) combined with SSRIs also improves outcomes . Other strategies include switching to intravenous clomipramine or another SSRI, though these require further validation .
Herbal and Alternative Treatments
There is tentative evidence for the efficacy of certain herbal medicines and phytochemicals in treating OCD. Compounds like Crocus sativus, Silybum marianum, and cannabidiol have shown potential anti-OCD effects, primarily through serotonin reuptake inhibition . However, these findings are preliminary and require more rigorous clinical trials for confirmation.
Compulsive Sexual Behavior Disorder: Emerging Pharmacological Options
SSRIs and Naltrexone
Compulsive Sexual Behavior Disorder (CSBD) is another area where pharmacological treatments are being explored. SSRIs and naltrexone are the most studied options. A double-blind, randomized trial found that both paroxetine (an SSRI) and naltrexone were safe and led to significant improvements in CSBD symptoms compared to placebo . However, the evidence is still limited, and further research is needed to confirm these findings and explore their efficacy in diverse populations Borgogna2023Lew-Starowicz2023.
Conclusion
While pharmacological treatments for compulsive disorders like CBD, OCD, and CSBD show promise, they are often limited by inconsistent efficacy and side effects. SSRIs and clomipramine remain the cornerstone for OCD treatment, with augmentation strategies available for resistant cases. For CBD and CSBD, no definitive pharmacological treatments exist, underscoring the need for further research to identify effective therapies.
Sources and full results
Most relevant research papers on this topic